Skip to content
ppharmaranks
Menu

Best treatments for cardiogenic shock

7 products may treat cardiogenic shock, spanning FDA drug classes such as antihypoglycemic agent, gastrointestinal motility inhibitor, cardiac glycoside. The current highest-rated option is baqsimi. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 7 drugs we list for cardiogenic shock, all are available as lower-cost generics, spanning classes such as antihypoglycemic agent, gastrointestinal motility inhibitor, cardiac glycoside. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for cardiogenic shock — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for cardiogenic shock: 1. Baqsimi · 2. Lanoxin Pediatric · 3. Gvoke Hypopen

Top-rated treatments for cardiogenic shock, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$5931View →
270/100$0View →
3Not yet rated$5931View →
4Not yet rated$5931View →
5Not yet rated$5931View →
6Not yet rated$5931View →
7Not yet rated$0View →

Full ranking · 7 treatments

baqsimi

PrescriptionFDA-sourced

70/100

Baqsimi (Glucagon) is an antihypoglycemic agent used to treat Anaphylaxis, Bradycardia, Hypoglycemia, Hypotension.

(1 data points)
antihypoglycemic agentgastrointestinal motility inhibitoranaphylaxis

Pharmacy pays

From ~$5930.62/30· 2 forms
View details →

lanoxin pediatric

PrescriptionFDA-sourced

70/100

Lanoxin Pediatric (Digoxin) is a cardiac glycoside used to treat Anxiety Disorders, Atrial Fibrillation, Atrial Flutter, Low Cardiac Output.

(3 data points)
cardiac glycosideanxiety disordersatrial fibrillation

Pharmacy pays

From ~$0.12· 6 forms
View details →

gvoke hypopen

PrescriptionFDA-sourced

New

Gvoke Hypopen (Glucagon) is an antihypoglycemic agent used to treat Anaphylaxis, Bradycardia, Hypoglycemia, Hypotension.

antihypoglycemic agentgastrointestinal motility inhibitoranaphylaxis

Pharmacy pays

From ~$5930.62/30· 2 forms
View details →

gvoke kit

PrescriptionFDA-sourced

New

Gvoke Kit (Glucagon) is an antihypoglycemic agent used to treat Anaphylaxis, Bradycardia, Hypoglycemia, Hypotension.

antihypoglycemic agentgastrointestinal motility inhibitoranaphylaxis

Pharmacy pays

From ~$5930.62/30· 2 forms
View details →

gvoke pfs

PrescriptionFDA-sourced

New

Gvoke Pfs (Glucagon) is an antihypoglycemic agent used to treat Anaphylaxis, Bradycardia, Hypoglycemia, Hypotension.

antihypoglycemic agentgastrointestinal motility inhibitoranaphylaxis

Pharmacy pays

From ~$5930.62/30· 2 forms
View details →

gvoke vialdx

PrescriptionFDA-sourced

New

Gvoke Vialdx (Glucagon) is an antihypoglycemic agent used to treat Anaphylaxis, Bradycardia, Hypoglycemia, Hypotension.

antihypoglycemic agentgastrointestinal motility inhibitoranaphylaxis

Pharmacy pays

From ~$5930.62/30· 2 forms
View details →

Frequently asked

What treats cardiogenic shock?
Our catalog lists 7 products that may treat cardiogenic shock, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is baqsimi.
What is the best-rated treatment for cardiogenic shock?
By our independent recall-safety rating — not an efficacy measure — baqsimi ranks highest among the products we list for cardiogenic shock. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat cardiogenic shock?
Treatments for cardiogenic shock span FDA drug classes including antihypoglycemic agent, gastrointestinal motility inhibitor, cardiac glycoside. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.